MUSTANG BIO, INC. Cash and Cash Equivalents
MUSTANG BIO, INC. (MBIO) had Cash and Cash Equivalents of $15.15 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $15.15M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $16.26M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $17.27M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $18.98M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $15.15M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $16.26M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $17.27M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $18.98M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $12.66M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $14.23M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $6.84M 10-K · filed 2026-03-19 |
| 2024-09-30 | $3.52M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $4.27M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.23M 10-K · filed 2025-03-28 |
| 2023-09-30 | $9.56M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $15.38M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $58.10M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $75.66M 10-K · filed 2024-03-11 |
| 2022-09-30 | $91.36M 10-Q · filed 2023-11-14 |
| 2022-06-30 | $107.37M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $122.22M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $109.62M 10-K · filed 2023-03-30 |
| 2021-09-30 | $120.88M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $129.92M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $129.37M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $97.80M 10-K · filed 2022-03-23 |
| 2020-09-30 | $75.25M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $85.36M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $55.81M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $61.41M 10-K · filed 2021-03-24 |
| 2019-09-30 | $72.79M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $16.47M 10-K · filed 2020-03-16 |
| 2017-09-30 | $33.21M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $53.79M 10-Q · filed 2017-08-14 |
| 2016-12-31 | $27.50M 10-Q · filed 2017-11-14 |
| 2016-09-30 | $11.12M 10-Q · filed 2017-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-14 |
| 2015-12-31 | $0.00 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |